Fungal Pathogens in CF Airways: Leave or Treat?

A Singh1, A Ralhan1, C Schwarz2

  • 1Department of Pediatrics, Pediatric Infectiology, Immunology and Cystic Fibrosis, Children's Hospital, University of Tübingen, Hoppe-Seyler-Str. 1, 72076, Tübingen, Germany.

Mycopathologia
|August 4, 2017
PubMed

Insights

Fungi like Aspergillus fumigatus are increasingly found in cystic fibrosis (CF) airways. This review explores their role in CF lung disease, distinguishing infection from colonization.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Chronic airway infections are central to cystic fibrosis (CF) lung disease progression.
  • Bacterial pathogens like Pseudomonas aeruginosa have historically dominated research, but fungal presence is common.
  • Emerging evidence suggests fungi, including Aspergillus fumigatus and Candida albicans, may influence CF lung disease.

Purpose of the Study:

  • To review the pathophysiological mechanisms and clinical impact of fungal presence in CF airways.
  • To differentiate between fungal colonization, sensitization, and infection in the context of CF lung disease.
  • To summarize current understanding of fungal-host interactions in CF.

Main Methods:

  • Literature review of in vitro and in vivo studies.
  • Analysis of clinical data associating fungal presence with CF lung disease course.
  • Discussion of immune response mechanisms in CF airways towards fungi.

Main Results:

  • Fungi are frequently detected in CF airways, with Aspergillus fumigatus and Candida albicans being common.
  • Impaired immune responses in CF patients may increase susceptibility to fungal pathogens.
  • The precise role of fungi—whether active participants or bystanders—in CF lung disease pathology remains under investigation.

Conclusions:

  • Fungi represent a significant, yet not fully understood, factor in cystic fibrosis lung disease.
  • Distinguishing fungal colonization from active infection is crucial for understanding their impact.
  • Further research is needed to elucidate the mechanisms and clinical significance of fungal-host interactions in CF.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
580
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
944
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
606
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
680
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K